Back to results
US 12,178,813 B2Granted
CGRP receptor antagonists
AssigneeNxera Pharma UK Limited
InventorsJohn Andrew Christopher, Miles Stuart Congreve, Sarah Joanne Bucknell, Francesca Deflorian, Mark Pickworth, Jonathan Stephen Mason
Life of this patent
Estimating the term…
Abstract
The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Claims22
A pharmaceutical composition comprising a) a compound of formula (I):
- or a salt thereof, an optical isomer thereof, or a combination thereof,
- wherein R1 is H or Q-(C1-C6)alkyl;
- where Q is a bond, C(O) or C(O)O and where the (C1-C6)alkyl can be optionally substituted by N(C1-C3alkyl)2 or CO2H;
- R2 is H or forms a spirocyclic heterocyclic ring with R3;
- R3 forms a spirocyclic heterocyclic ring with R2 or is a heterocyclic ring if R2 is H;
- and
- R4 is an optionally substituted aryl group which may be monocyclic or fused to a further ring;
- and
- b) one or more pharmaceutically acceptable carriers.
6 more elements
Dependencies are inferred from the claim text.